Does NeuBase Therapeutics Inc. (NASDAQ:NBSE) warrant a purchase right now? What to Consider Before Making a Decision
NeuBase Therapeutics Inc. (NASDAQ:NBSE) shares traded -21.43% lower at $1.87 on Wall Street last session. In accordance with the data, 1 analysts cover NeuBase Therapeutics Inc. (NASDAQ:NBSE). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $200.00 and a low of $200.00, […]